silybin has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebadi, SA; Eyvari Brooshghalan, S; Haddadi, R; Mohajjel Nayebi, A; Sabahi, M; Sadeghian, Z | 1 |
| Fu, J; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, W; Liu, X; Mizuno, K; Song, S; Wang, C | 1 |
2 other study(ies) available for silybin and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling.
Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Interleukin-6; Molecular Docking Simulation; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Rats; Silybin; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2023 |
Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; alpha-Synuclein; Animals; Apoptosis; Cerebral Cortex; Cognitive Dysfunction; Hippocampus; Male; Memantine; Mice, Inbred C57BL; Mitochondria; Mitochondrial Diseases; Morris Water Maze Test; Neurons; Neuroprotective Agents; Open Field Test; Oxidative Stress; Parkinsonian Disorders; Silybin | 2021 |